Access to Vaccination for Newly Arrived Migrants (AcToVx4NAM)

• Access to Vaccination for Newly Arrived Migrants (AcToVx4NAM) is a 3-year European project with a mission to increase the vaccination uptake in Newly Arrived Migrants (NAM). The beneficiaries are Newly Arrived Migrants (NAM) in first line transit and destination EU/EEA countries, regardless of their legal status.
• The general objective of the AcToVax4NAM project is the improvement of the health system’s Vaccination Literacy (VL) and access, by making access conditions more equitable and guaranteed, thereby leading to increased vaccination uptake by Newly Arrived Migrants (NAM). The project will target Vaccine Preventable Diseases (VPDs) that are part of National Immunization Plans, as well as COVID-19 Plans, and will adopt a life course and participatory approach.
• The project targets all “professional FOR health” who have a significant impact on NAM vaccination. Therefore, our target groups are all health and social care professional who are involved in the vaccination of NAM, such as: Staff of public health institutions at national and local level, Staff of Migrant Reception & Vaccination Centers, Cultural mediators, social workers, Personnel working for NGOs in areas related to migrants’ health, Health Professionals (doctors/nurses/others).

• Promote tools and solutions to increase vaccination uptake among NAMs readily available at EU level.
• Availability of validated country-specific flow charts that guide target groups out of system barriers to acceptable and feasible solutions.
• Increase knowledge about strategies and tools that work in promoting and increasing vaccinations among NAMs and among professionals working with NAM.
• Increase awareness among target groups and stakeholders about the existence of system barriers in the consortium countries that pose difficulties for the vaccination of NAMs.
• Improve system health literacy and navigation regarding vaccinations among professionals working with NAM.
• Increase vaccination uptake among NAM in identified settings.

P1: Prolepsis Institute, Greece (Coordinator)

P2: National Institute of Health, National Centre for Global Health (Italy)

P3: Sapienza – University of Rome – Department of Public Health and Infectious Diseases (Italy)

P4: Center for Social Innovation (Cyprus)

P5: Ministry of Health, Directorate of Operational Preparedness for Public Health Emergencies (EKDY) (Greece)

P6: Ethno-Medical Centre (Germany)

P7: Nation Institute of Public Health NIH, National Research Institute (Poland)

P8: Ministry of Health, Infectious Disease Prevention and Control Unit (Malta)

P9: Vall d’Hebron Research Institute (Spain)

P10: Romtens Foundation (Romania)